Metastatic organotropism in small cell lung cancer

Manan Krishnamurthy,Anjali Dhall,Christopher W. Schultz,Michelle A. Baird,Parth Desai,Jacob Odell,Sarthak Sahoo,Nobuyuki Takahashi,Michael Nirula,Sophie Zhuang,Yue Huang,Brett Schroeder,Yang Zhang,Maria Sebastian Thomas,Christophe Redon,Christina Robinson,Lai Thang,Lilia Ileva,Nimit L. Patel,Joseph D. Kalen,Alice-Anais Varlet,Noam Zuela-Sopilniak,Ankita Jha,Darawalee Wangsa,Donna Butcher,Tamara Morgan,Alyah N. Afzal,Raj Chari,Karim Baktiar,Suresh Kumar,Lorinc Pongor,Simone Difilippantonio,Mirit I. Aladjem,Yves Pommier,Mohit Kumar Jolly,Jan Lammerding,Ajit Kumar Sharma,Anish Thomas
DOI: https://doi.org/10.1101/2024.10.07.617066
2024-10-08
Abstract:Metastasis is the leading cause of cancer-related deaths, yet its regulatory mechanisms are not fully understood. Small-cell lung cancer (SCLC) is the most metastatic form of lung cancer, with most patients presenting with widespread disease, making it an ideal model for studying metastasis. However, the lack of suitable preclinical models has limited such studies. We utilized well-annotated rapid autopsy-derived tumors to develop xenograft models that mimic key features of SCLC, including histopathology, rapid and widespread development of metastasis to the liver, brain, adrenal, bone marrow, and kidneys within weeks, and response to chemotherapy. By integrating in vivo lineage selection with comprehensive transcriptomic and epigenomic analyses, we identified critical cellular programs driving metastatic organotropism to the liver and brain, the most common sites of SCLC metastasis. Our findings reveal the key role of nuclear-cytoskeletal interactions in SCLC liver metastasis. Specifically, the loss of the nuclear envelope protein lamin A/C, encoded by the LMNA gene, increased nuclear deformability and significantly increased the incidence of liver metastasis. Human liver metastases exhibited reduced LMNA expression compared to other metastatic sites, correlating with poorer patient outcomes and increased mortality. This study introduces novel preclinical models for SCLC metastasis and highlights pathways critical for organ-specific metastasis, offering new avenues for the development of targeted therapies to prevent or treat metastatic disease.
Cancer Biology
What problem does this paper attempt to address?